Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarek Assi

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Bulletin Du Cancer|October 7, 2019
[A breast cancer case in the only Lebanese family with Fabry disease]Fadi Farhat, Mohamad Tarabaih, Joseph Kattan, et al.
Future Oncology (London, England)|July 2, 2021
Immune checkpoints inhibitors in metastatic squamous cell carcinoma of the vulvaTarek Assi, Joseph Kattan, Ahmad Othman, et al.
The Gulf Journal of Oncology|October 23, 2018
Life threatening bleeding from an osteonecrosis of the jaw: Are bisphosphonates safe in irradiated head and neck cancer patients?Tarek Assi, Ralph Chebib, Sara Lakiss, et al.
Pharmacogenomics|March 7, 2024
Targeting RET mutation in medullary thyroid cancerTarek Assi, Zamzam Tikriti, Annoir Shayya, et al.
Immunotherapy|March 18, 2017
Diffuse edema suggestive of cytokine release syndrome in a metastatic lung carcinoma patient treated with pembrolizumabElie El Rassy, Tarek Assi, Jamale Rizkallah, et al.
Journal of Clinical Gastroenterology|December 22, 2018
Second-line Treatments of Advanced Hepatocellular Carcinoma: Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsZiad Bakouny, Tarek Assi, Elie El Rassy, et al.
Immunotherapy|April 3, 2026
Immune checkpoint inhibitors in dedifferentiated chondrosarcoma: toward breaking therapeutic resistanceTarek Assi, Tania Moussa, Rebecca Ibrahim, et al.
Case Reports in Otolaryngology|August 4, 2015
Solitary Laryngeal Metastasis from Transitional Cell Carcinoma of the Kidney: Clinical Case and Review of the LiteratureTarek Assi, Elie El Rassy, Amine Haddad, et al.
Future Oncology (London, England)|August 24, 2017
PDL-1/PD1 inhibitors: antibody or antinobody?Fouad Aoun, Elie El Rassy, Tarek Assi, et al.
Future Oncology (London, England)|March 13, 2018
Different inhibitors for the same target in metastatic luminal breast cancer: is there any difference?Elie El Rassy, Ziad Bakouny, Tarek Assi, et al.
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Bulletin Du Cancer|October 7, 2019
[A breast cancer case in the only Lebanese family with Fabry disease]Fadi Farhat, Mohamad Tarabaih, Joseph Kattan, et al.
Future Oncology (London, England)|July 2, 2021
Immune checkpoints inhibitors in metastatic squamous cell carcinoma of the vulvaTarek Assi, Joseph Kattan, Ahmad Othman, et al.
The Gulf Journal of Oncology|October 23, 2018
Life threatening bleeding from an osteonecrosis of the jaw: Are bisphosphonates safe in irradiated head and neck cancer patients?Tarek Assi, Ralph Chebib, Sara Lakiss, et al.
Pharmacogenomics|March 7, 2024
Targeting RET mutation in medullary thyroid cancerTarek Assi, Zamzam Tikriti, Annoir Shayya, et al.
Immunotherapy|March 18, 2017
Diffuse edema suggestive of cytokine release syndrome in a metastatic lung carcinoma patient treated with pembrolizumabElie El Rassy, Tarek Assi, Jamale Rizkallah, et al.
Journal of Clinical Gastroenterology|December 22, 2018
Second-line Treatments of Advanced Hepatocellular Carcinoma: Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsZiad Bakouny, Tarek Assi, Elie El Rassy, et al.
Immunotherapy|April 3, 2026
Immune checkpoint inhibitors in dedifferentiated chondrosarcoma: toward breaking therapeutic resistanceTarek Assi, Tania Moussa, Rebecca Ibrahim, et al.
Case Reports in Otolaryngology|August 4, 2015
Solitary Laryngeal Metastasis from Transitional Cell Carcinoma of the Kidney: Clinical Case and Review of the LiteratureTarek Assi, Elie El Rassy, Amine Haddad, et al.
Future Oncology (London, England)|August 24, 2017
PDL-1/PD1 inhibitors: antibody or antinobody?Fouad Aoun, Elie El Rassy, Tarek Assi, et al.
Future Oncology (London, England)|March 13, 2018
Different inhibitors for the same target in metastatic luminal breast cancer: is there any difference?Elie El Rassy, Ziad Bakouny, Tarek Assi, et al.
Pageof 12